Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways

Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways

<p>Figure S2. Lurbinectedin sensitivity (IC50) correlation with MYC expression and changes in expression of NE markers.</p>

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Subhamoy Chakraborty (16648124) (author)
Andere auteurs: Charles Coleman (16648127) (author), Parvathy Manoj (16648130) (author), Deniz Demircioglu (15306139) (author), Nisargbhai Shah (16648133) (author), Elisa de Stanchina (14954757) (author), Charles M. Rudin (11572933) (author), Dan Hasson (15306151) (author), Triparna Sen (14126577) (author)
Gepubliceerd in: 2025
Onderwerpen:
Cancer
Cancer Detection and Diagnosis
Methods and Technology
Biomarkers
Lung Cancer
Preclinical Models
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items